LY5 is a STAT3 inhibitor with an IC 50 value of 0.5 μM. LY5 induces apoptosis and inhibits STAT3 phosphorylation. LY5 shows antitumor activity in vivo, it can be used for the research of cancer.
IC50 & Target[1][2]
IC50: 0.5 μM (STAT3)
体外研究(In Vitro)
LY5 shows inhibition effects to U2OS, RH30 and RD2 cancer cells with IC50 values of 0.52, 0.55 and 1.39 μM, respectively.LY5 (0.25-1 μM; 16 h) induces apoptosis and inhibits STAT3 phosphorylation in human sarcoma cancer cells.LY5 (0.25-1 μM; 5 h) inhibits STAT3 phosphorylation induced by IL-6. has not independently confirmed the accuracy of these methods. They are for reference only.Western Blot Analysis
体内研究(In Vivo)
LY5 (5 mg/kg; i.p. once daily for 21 days) inhibits breast tumor growth in vivo. has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: Nude mice with MDA-MB-231 cancer cells injection
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献
[1]. Yu W, et al. Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design. J Med Chem. 2013 Jun 13;56(11):4402-12.